Pranoprofen

Independent reference data for Pranoprofen (CAS 52549-17-4), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.

Synonyms and trade names

pranoprofen; 52549-17-4; pyranoprofen; Pranoprofeno; Pranoprofene; Pranoprofenum; Elicapric; DTXSID1023497; NSC-759832; 2R7O1ET613; DTXCID603497; alpha-Methyl-5H-(1)benzopyrano(2,3-b)pyridine-7-acetic acid; (+-)-Pranoprofen; RefChem:868380; S01BC09; (2RS)-2-(10H-9-Oxa-1-azaanthracen-6-yl)propanoic acid

GHS hazard classification

Reported hazard statements	H301 (100%), H315 (33.3%), H319 (33.3%)

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

H315 (33.3%): Causes skin irritation [Warning Skin corrosion/irritation]

What the public record says

Pranoprofen · CAS 52549-17-4 · C15H13NO3. UNII 2R7O1ET613.

Source: PubChem / Wikidata; the batch COA governs where values differ.